Clinical trial
Docetaxel in Treating Patients With Stage IV Prostate Cancer
NCT00003781 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00003781 |
|---|---|
| Title | Docetaxel in Treating Patients With Stage IV Prostate Cancer |
| Official title | Phase II Study of Weekly Docetaxel (Taxotere) in Hormone Refractory Metastatic Prostate Cancer |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Prostate Cancer |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, pain therapy, quality-of-life assessment |
| Enrollment | 25 |
| Start date | Dec 1, 1998 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Jul 22, 2004 |
| Last update posted | Apr 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: